Related Experiment Video

Updated: Nov 30, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

10.1K

A CRISPR-Cas9 repressor for epigenetic silencing of KRAS

Jingwen Liu1, Meiyan Sun2, Kwang Bog Cho1

  • 1Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX, 77204, United States.

Pharmacological Research
|November 17, 2020
PubMed

Insights

Scientists developed a novel CRISPR-Cas9 epigenetic repressor to silence KRAS oncogenes. This approach effectively inhibited cancer cell growth and induced cell death in KRAS-mutated cancers.

Area of Science:

  • Molecular Biology
  • Cancer Genetics
  • Epigenetics

Background:

  • KRAS is a frequently mutated oncogene driving various cancers.
  • Current anti-KRAS therapies lack direct efficacy.
  • Targeting oncogene promoters offers a potential therapeutic strategy.

Purpose of the Study:

  • To develop a novel epigenetic repressor for KRAS silencing using CRISPR-Cas9.
  • To evaluate the efficacy of KRAS suppression in cancer cells.
  • To explore a new therapeutic strategy for KRAS-mutated cancers.

Main Methods:

  • Designed a CRISPR-Cas9-based epigenetic repressor fusing dCas9 with HDAC1.
  • Utilized CRISPR RNAs (crRNAs) to target the KRAS promoter region.
  • Assessed KRAS silencing via cell growth inhibition, colony formation assays, and ChIP assays.

Main Results:

  • Identified specific crRNAs (crRNA1 and crRNA2) that efficiently silenced KRAS.
  • Demonstrated significant inhibition of cancer cell growth, colony formation, and induction of cell death.
  • Confirmed epigenetic modification of the KRAS promoter via dCas9-HDAC1-mediated histone acetylation changes.

Conclusions:

  • Developed a novel CRISPR-Cas9 and HDAC1-based epigenetic silencing strategy for KRAS.
  • This approach effectively suppresses KRAS activity and inhibits proliferation in KRAS-mutated cancer cells.
  • Represents a promising new therapeutic avenue for cancers driven by KRAS mutations.
Keywords:
CRISPREpigeneticsHDAC1KRAS mutationsRibonucleoprotein

More Related Videos

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.7K
CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

1.9K

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.1K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
55.5K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.2K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.4K